Abstract. MobiusFX, an add-on software module from Mobius Medical Systems for IMRT and VMAT QA, uses measurements in linac treatment logs to calculate and verify the 3D dose delivered to patients. In this study, 10 volumetric-modulated arc therapy (VMAT) prostate plans were planned and delivered in a Varian TrueBeam linac. The plans consisted of beams with 6 and 10 MV energy and 2 to 3 arcs per plan. The average gamma value with criterion of 3% and 3mm MobiusFX and TPS: 99.96%, 2% and 2mm MobiusFX and TPS: 98.70 %. Further comparison with ArcCheck measurements was conducted.
Introduction
The MobiusFX solution from Mobius Medical Systems (Mobius Medical Systems, Houston, TX) for IMRT QA uses linac treatment logs to calculate and verify the 3D dose delivered. One of the most attractive reasons to use this approach is that there is no need for ion-chamber, diode array, EPID, film, or any external measurements as historically used in the field [1] [2] [3] [4] [5] [6] [7] . Due to the nature of the Mobius FX method for IMRT QA, this in principle implies a faster method since no device needs to be positioned.
Methods and materials
In this study, 10 volumetric-modulated arc therapy (VMAT) prostate plans were planned and delivered in a Varian TrueBeam linac (Varian Medical Systems, Palo Alto, CA). All VMAT plans were delivered and measured at the same time with ArcCheck and Mobius means to ensure consistency in the data as shown in figure 1.
Results
Comparisons of profiles and gamma analyses were conducted on all VMAT QA plans (Figure 2) . In order to ensure impartiality for the study the 3D dose [8] obtained by Mobius FX method was exported and introduced into the SNCPA software to analyse the comparison against ArcCheck measurement and TPS. The average gamma value with criterion of 3% and 3mm of Mobius FX vs the Treatment Planning System (TPS) was 99.96%, and 2% and 2mm of Mobius FX vs TPS was 98.70%. Similar results were observed for ArcCheck and Mobius FX gamma analysis calculation and dose profiles ( Figure 3 ). 
Conclusions
MobiusFX is capable of producing similar results to those produced by traditional methods for patient specific pre-treatment verification VMAT QA. Even the gamma results compared with the TPS are similar.
